{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:58:28Z","timestamp":1787065108321,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-20-1-0913"],"award-info":[{"award-number":["W81XWH-20-1-0913"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijbiomac.2024.129295","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T11:28:49Z","timestamp":1704799729000},"page":"129295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P2","title":["Biophysical and biochemical characterization of a recombinant Lyme disease vaccine antigen, CspZ-YA"],"prefix":"10.1016","volume":"259","author":[{"given":"Yi-Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungsoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Strych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Pin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.129295_bb0005","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the frequency of Lyme disease diagnoses, United States, 2010-2018","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0010","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007744","article-title":"Global seroprevalence and sociodemographic characteristics of Borrelia burgdorferi sensu lato in human populations: a systematic review and meta-analysis","volume":"7","author":"Dong","year":"2022","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: a cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00917-19","article-title":"Broadly protective multivalent OspA vaccine against Lyme Borreliosis, developed based on surface shaping of the C-terminal fragment","volume":"88","author":"Nayak","year":"2020","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184357","article-title":"The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes","volume":"12","author":"Comstedt","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0035","first-page":"1405","article-title":"Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights","volume":"21","author":"Chen","year":"2022"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pt.2010.06.006","article-title":"Lyme borreliosis vaccination: the facts, the challenge, the future","volume":"27","author":"Schuijt","year":"2011","journal-title":"Trends Parasitol."},{"issue":"Suppl. 3","key":"10.1016\/j.ijbiomac.2024.129295_bb0045","doi-asserted-by":"crossref","first-page":"s259","DOI":"10.1093\/cid\/ciq117","article-title":"Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis","volume":"52","author":"Steere","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0050","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/cid\/ciz872","article-title":"Protective immunity and new vaccines for lyme disease","volume":"70","author":"Gomes-Solecki","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrmicro2714","article-title":"Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes","volume":"10","author":"Radolf","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0060","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41579-020-0400-5","article-title":"Interactions between Borrelia burgdorferi and ticks","volume":"18","author":"Kurokawa","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","article-title":"New insights into the immune functions of complement","volume":"19","author":"Reis","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molimm.2013.05.222","article-title":"Human complement control and complement evasion by pathogenic microbes--tipping the balance","volume":"56","author":"Zipfel","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/joim.12606","article-title":"The role of complement inhibitors beyond controlling inflammation","volume":"282","author":"Blom","year":"2017","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneph.2016.70","article-title":"Complement in disease: a defence system turning offensive","volume":"12","author":"Ricklin","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/41169409-3260-4295-baf4-a1a4621a8e48","article-title":"Microbes bind complement inhibitor factor H via a common site","volume":"9","author":"Meri","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0090","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.pt.2020.04.011","article-title":"Complement evasion contributes to Lyme Borreliae-host associations","volume":"36","author":"Lin","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2020.00001","article-title":"New insights into CRASP-mediated complement evasion in the Lyme disease enzootic cycle","volume":"10","author":"Lin","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0100","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1365-2958.2006.05318.x","article-title":"Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1","volume":"61","author":"Hartmann","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0105","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1128\/IAI.00850-07","article-title":"Delineation of species-specific binding properties of the CspZ protein (BBH06) of Lyme disease spirochetes: evidence for new contributions to the pathogenesis of Borrelia spp","volume":"75","author":"Rogers","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CVI.00415-07","article-title":"Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease","volume":"15","author":"Kraiczy","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0115","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1128\/IAI.00393-09","article-title":"Comparative analysis of the properties and ligand binding characteristics of CspZ, a factor H binding protein, derived from Borrelia burgdorferi isolates of human origin","volume":"77","author":"Rogers","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0120","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1128\/IAI.00604-07","article-title":"Coordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete\u2019s mammal-tick infection cycle","volume":"75","author":"Bykowski","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00181","article-title":"Eliminating factor H-binding activity of Borrelia burgdorferi CspZ combined with virus-like particle conjugation enhances its efficacy as a Lyme disease vaccine","volume":"9","author":"Marcinkiewicz","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00956-19","article-title":"The factor H-binding site of cspz as a protective target against multistrain, tick-transmitted Lyme disease","volume":"88","author":"Marcinkiewicz","year":"2020","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0135","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00062-22","article-title":"CspZ FH-binding sites as epitopes promote antibody-mediated Lyme Borreliae clearance","volume":"90","author":"Chen","year":"2022","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0140","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00253-002-1158-6","article-title":"M I N I-R E V I E W overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems","volume":"60","author":"Terpe","year":"2003","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107653","article-title":"Opportunities and challenges of the tag-assisted protein purification techniques: applications in the pharmaceutical industry","volume":"45","author":"Mahmoudi Gomari","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pep.2005.12.002","article-title":"Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins","volume":"48","author":"Arnau","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0155","article-title":"Eliminating factor H-binding activity of Borrelia burgdorferi CspZ combined with virus-like particle conjugation enhances its efficacy as a Lyme disease vaccine","volume":"9","author":"Marcnkiewicz","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0003-2697(87)90157-6","article-title":"Nile red as a polarity-sensitive fluorescent probe of hydrophobic protein surfaces","volume":"167","author":"Sackett","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0165","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s11095-007-9516-9","article-title":"Extrinsic fluorescent dyes as tools for protein characterization","volume":"25","author":"Hawe","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2021.129893","article-title":"Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate","volume":"1865","author":"Chen","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0175","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.xphs.2017.04.037","article-title":"Optimization of the production process and characterization of the yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1), a SARS vaccine candidate","volume":"106","author":"Chen","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0180","doi-asserted-by":"crossref","first-page":"W315","DOI":"10.1093\/nar\/gky497","article-title":"BeStSel: a web server for accurate protein secondary structure prediction and fold recognition from the circular dichroism spectra","volume":"46","author":"Micsonai","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0185","doi-asserted-by":"crossref","first-page":"E3095","DOI":"10.1073\/pnas.1500851112","article-title":"Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy","volume":"112","author":"Micsonai","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0190","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.chempr.2019.07.008","article-title":"Electronic circular dichroism spectroscopy of proteins","volume":"5","author":"Rogers","year":"2019","journal-title":"Chem"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0195","article-title":"Recent progress in lyme disease and remaining challenges","volume":"8","author":"Bobe","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.129295_bb0200","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nature Reviews Genetics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129295_bb0205","first-page":"1","article-title":"Coronavirus vaccine development: from SARS and MERS to COVID-19","volume":"27","author":"Der Li","year":"2020","journal-title":"Journal of Biomedical Science"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0210","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","article-title":"mRNA vaccines manufacturing: challenges and bottlenecks","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/vaccines7040122","article-title":"Enlisting the mRNA vaccine platform to combat parasitic infections","volume":"7","author":"Versteeg","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0220","unstructured":"Vaccine Types | NIH: National Institute of Allergy and Infectious Diseases, (n.d.). https:\/\/www.niaid.nih.gov\/research\/vaccine-types (accessed August 20, 2023)."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0225","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1590\/S0100-879X2012007500142","article-title":"Recombinant vaccines and the development of new vaccine strategies","volume":"45","author":"Nascimento","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0230","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.xphs.2017.12.014","article-title":"Characterization and stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a candidate antigen for a therapeutic vaccine against Chagas disease","volume":"107","author":"Biter","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0235","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.4161\/hv.28872","article-title":"Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate","volume":"10","author":"Curti","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129295_bb0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s13346-021-00924-7","article-title":"Development of vaccine formulations: past, present, and future","volume":"11","author":"D\u2019Amico","year":"2021","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0245","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4161\/self.1.4.13904","article-title":"Immunogenicity of protein therapeutics: the key causes, consequences and challenges","volume":"1","author":"Baker","year":"2010","journal-title":"Self Nonself."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0250","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.3390\/pharmaceutics14112533","article-title":"Instability challenges and stabilization strategies of pharmaceutical proteins","volume":"14","author":"Akbarian","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660198","article-title":"Enhancing the prefusion conformational stability of SARS-CoV-2 spike protein through structure-guided design","volume":"12","author":"Riley","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/1547691X.2013.821564","article-title":"Immunogenicity of therapeutic proteins: influence of aggregation","volume":"11","author":"Ratanji","year":"2014","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0265","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2011.09.017","article-title":"Impact of short range hydrophobic interactions and long range electrostatic forces on the aggregation kinetics of a monoclonal antibody and a dual-variable domain immunoglobulin at low and high concentrations","volume":"421","author":"Kumar","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/jcs7010028","article-title":"Critical influences of plasma pH on human protein properties for modeling considerations: size, charge, conformation, hydrophobicity, and denaturation","volume":"7","author":"Mapiour","year":"2023","journal-title":"Journal of Composites Science"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0280","first-page":"1193","article-title":"Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes","volume":"6","author":"Garro","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01663-7","article-title":"The role of surface properties on protein aggregation behavior in aqueous solution of different pH values","volume":"21","author":"Lan","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0290","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.bpj.2010.08.020","article-title":"Diffusion and sedimentation interaction parameters for measuring the second virial coefficient and their utility as predictors of protein aggregation","volume":"99","author":"Saluja","year":"2010","journal-title":"Biophys. J."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.129295_bb0295","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nature Protocols"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0300","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1111\/febs.12808","article-title":"Structural characterization of CspZ, a complement regulator factor H and FHL-1 binding protein from Borrelia burgdorferi","volume":"281","author":"Brangulis","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0305","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1039\/D0MA00760A","article-title":"Review of the current state of protein aggregation inhibition from a materials chemistry perspective: special focus on polymeric materials","volume":"2","author":"Rajan","year":"2021","journal-title":"Mater Adv."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0310","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/prot.10468","article-title":"Mechanism for the alpha-helix to beta-hairpin transition","volume":"53","author":"Ding","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0315","doi-asserted-by":"crossref","first-page":"40235","DOI":"10.1074\/jbc.M506372200","article-title":"Direct observation of protein folding, aggregation, and a prion-like conformational conversion","volume":"280","author":"Ding","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0320","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Protein folding and misfolding","volume":"426","author":"Dobson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0325","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ijbiomac.2022.04.077","article-title":"Expression, purification, and biophysical characterization of recombinant MERS-CoV main (Mpro) protease","volume":"209","author":"Almutairi","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0330","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.4161\/hv.25788","article-title":"Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasis","volume":"9","author":"Cheng","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0335","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1039\/C5SM00954E","article-title":"Salting-out and salting-in: competitive effects of salt on the aggregation behavior of soy protein particles and their emulsifying properties","volume":"11","author":"Xu","year":"2015","journal-title":"Soft Matter"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0340","first-page":"23","article-title":"The ability of salts to stabilize proteins in vivo or intracellularly correlates with the Hofmeister series of ions","volume":"10","author":"Hani","year":"2019","journal-title":"Int J Biochem Mol Biol."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-12-374727-3.00008-5","article-title":"Stringency: conditions that influence nucleic acid structure","author":"Farrell","year":"2010","journal-title":"RNA Methodologies."},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0350","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0003-2670(01)84768-1","article-title":"References standards for the electrometric determination, with ion-selective electrodes, of potassium and calcium in blood serum","volume":"78","author":"Covington","year":"1975","journal-title":"Anal. Chim. Acta"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.129295_bb0355","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s13361-017-1739-3","article-title":"Addressing a common misconception: ammonium acetate as neutral pH \u201cBuffer\u201d for native electrospray mass spectrometry","volume":"28","author":"Konermann","year":"2017","journal-title":"Journal of The American Society for Mass Spectrometry"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0360","series-title":"Proteins: Structures and Molecular Properties","first-page":"507","author":"Creighton","year":"1993"},{"key":"10.1016\/j.ijbiomac.2024.129295_bb0365","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1529\/biophysj.105.071050","article-title":"Salting the charged surface: pH and salt dependence of protein G B1 stability","volume":"90","author":"Lindman","year":"2006","journal-title":"Biophys. J."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024000989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024000989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:10:57Z","timestamp":1758885057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":73,"alternative-id":["S0141813024000989"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129295","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biophysical and biochemical characterization of a recombinant Lyme disease vaccine antigen, CspZ-YA","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"129295"}}